The human gut microbiome represents one of the most complex and dynamic ecosystems within the human body, comprising trillions of microorganisms that play crucial roles in health and disease. This comprehensive review examines the intricate relationship between gut microbiome diversity, immune system modulation, and disease pathogenesis. Recent advances in metagenomics and systems biology have revealed that microbiome dysbiosis is implicated in numerous conditions ranging from inflammatory bowel disease and metabolic disorders to neurological conditions and cancer. The gut-immune axis serves as a critical communication pathway, where microbial metabolites, particularly short-chain fatty acids, influence both local and systemic immune responses. Understanding these complex interactions has opened new therapeutic avenues, including personalized microbiome interventions, targeted probiotics, and fecal microbiota transplantation. This review synthesizes current knowledge on microbiome diversity patterns, immune-microbe crosstalk mechanisms, and clinical implications for disease prevention and treatment.